As expected, NF-κB activation (as assessed by measuring IκB-α phosphorylation and expression levels of the representative Th2 cytokines IL-4 and IL-13) was significantly downregulated in sST2-expressing tumours compared with sST2-deficient tumours. This evidence concerns the gene NFKB1 and neoplasm.